These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16012850)

  • 1. Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67.
    Gomaa W; Ke Y; Fujii H; Helliwell T
    Virchows Arch; 2005 Oct; 447(4):701-9. PubMed ID: 16012850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of tissue array technology in head and neck squamous cell carcinoma.
    Chen B; van den Brekel MW; Buschers W; Balm AJ; van Velthuysen ML
    Head Neck; 2003 Nov; 25(11):922-30. PubMed ID: 14603452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
    Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
    Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of primary site biopsies in head and neck squamous cell carcinoma.
    Moertel S; Ackermann H; Baghi M; Eckardt A; Wagenblast J; Stöver T; Hambek M
    Anticancer Res; 2011 Feb; 31(2):665-9. PubMed ID: 21378353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients.
    Wong MP; Cheang M; Yorida E; Coldman A; Gilks CB; Huntsman D; Berean K
    Pathology; 2008 Oct; 40(6):611-6. PubMed ID: 18752129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
    Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
    Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis.
    Fischer CA; Jung M; Zlobec I; Green E; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano LM
    Head Neck; 2011 Feb; 33(2):267-73. PubMed ID: 20848449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus.
    Boone J; van Hillegersberg R; van Diest PJ; Offerhaus GJ; Rinkes IH; Kate FJ
    Virchows Arch; 2008 May; 452(5):507-14. PubMed ID: 18392848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
    Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
    Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative expression of vascular endothelial growth factor isoforms in squamous cell carcinoma of the head and neck.
    Wilkie MD; Emmett MS; Santosh S; Lightbody KA; Lane S; Goodyear PW; Sheard JD; Boyd MT; Pritchard-Jones RO; Jones TM
    Head Neck; 2016 May; 38(5):775-81. PubMed ID: 25521093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of tissue microarrays using p53 immunohistochemical studies of squamous cell carcinoma of the larynx.
    Griffin MC; Robinson RA; Trask DK
    Mod Pathol; 2003 Dec; 16(12):1181-8. PubMed ID: 14681317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays.
    Gulmann C; Butler D; Kay E; Grace A; Leader M
    Histopathology; 2003 Jan; 42(1):70-6. PubMed ID: 12493028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study.
    Silva SD; Agostini M; Nishimoto IN; Coletta RD; Alves FA; Lopes MA; Kowalski LP; Graner E
    Oral Oncol; 2004 Aug; 40(7):688-96. PubMed ID: 15172638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis.
    Kyzas PA; Cunha IW; Ioannidis JP
    Clin Cancer Res; 2005 Feb; 11(4):1434-40. PubMed ID: 15746043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ki67, p53 and cyclin D1 in the squamous cell carcinoma of head and neck].
    Golusiński W; Golusiński P; Stańczak J; Kłosin J
    Otolaryngol Pol; 2004; 58(4):777-84. PubMed ID: 15603389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
    Fabricius EM; Kruse-Boitschenko U; Khoury R; Wildner GP; Raguse JD; Klein M
    Int J Oncol; 2009 May; 34(5):1257-79. PubMed ID: 19360339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck.
    Bowden J; Brennan PA; Umar T; Cronin A
    J Cutan Pathol; 2002 Nov; 29(10):585-9. PubMed ID: 12453295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
    Ricker JL; Chen Z; Yang XP; Pribluda VS; Swartz GM; Van Waes C
    Clin Cancer Res; 2004 Dec; 10(24):8665-73. PubMed ID: 15623651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.
    Raleigh JA; Chou SC; Calkins-Adams DP; Ballenger CA; Novotny DB; Varia MA
    Clin Cancer Res; 2000 Mar; 6(3):855-62. PubMed ID: 10741707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.